Trial Profile

24 Week Open Label, Single Arm Study of Colesevelam in High Risk South Asians With Suboptimal LDL-c Levels Despite Maximally Tolerated Statin Therapy

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 24 Jan 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Colesevelam (Primary)
Indications Coronary artery disease; Type 2 diabetes mellitus
Focus Therapeutic Use
Acronyms CLASS-ACT

Most Recent Events

22 Jan 2020 Status changed from recruiting to completed.
26 Oct 2017 Planned End Date changed from 1 Dec 2017 to 28 Feb 2018.
26 Oct 2017 Planned primary completion date changed from 1 Jul 2017 to 15 Feb 2018.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com